New Study Could Help Make Mesothelioma Diagnosis and Treatment Much Faster; Baron and Budd Applauds Advancement, Hopes Study Can Help Patients

Differentiation Between Malignant Pleural Mesothelioma and Non-Cancerous Conditions Can Help Enhance Chances for Survival

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

DALLAS (PRWEB) July 02, 2014

The Journal of Molecular Diagnostics has published a study that could be a significant help in correctly diagnosing malignant pleural mesothelioma. The disease can be extremely difficult to distinguish from reactive mesothelial proliferations, a common issue that is non-cancerous. By being able to accurately differentiate between the two conditions earlier, treatment for malignant pleural mesothelioma can take place much faster. The law firm is Baron and Budd is happy to applaud this progress is mesothelioma, a cancer that generally gets little attention. (Science Codex, June 6, 2014; http://www.sciencecodex.com/biomarkers_accurately_distinguish_mesothelioma_from_noncancerous_tissue-135150)

Mesothelioma, a disease that primarily results from exposure to asbestos, can be extremely difficult to diagnose accurately. The main reason is that its symptoms often mimic those of other illnesses. The goal of the study, which is headed by Eric Santoni-Rugju, MD, PhD, is to identify microRNAs – non-coding strands of RNA – that can help differentiate between malignant pleural mesothelioma from reactive mesothelial proliferations. MicroRNAs are used to diagnose and predict the behavior of other forms of cancers.

The scientists involved in the study, which took place at the Copenhagen University Hospital in Copenhagen, Denmark, used four biomarkers that can help increase the accuracy of mesothelioma diagnoses. By using microRNA strands, the accuracy of classifying tissue as malignant pleural mesothelioma or reactive mesothelial proliferations has been as high as 94 percent.

“This is obviously not just excellent news – it could potentially serve as a turning point in the successful treatment of this devastating disease,” said Russell Budd, managing director of mesothelioma law firm Baron & Budd. “The strides being made by this research team could eventually bring hope to countless mesothelioma patients.”

The national law firm of Baron and Budd has helped mesothelioma patients and their families for more than 35 years. If you or someone you know is suffering from this disease, please call 1.866.855.1229 or visit our website at http://www.fightmesothelioma.com to learn more of how we may be of assistance.

ABOUT BARON AND BUDD

With a history of over 35 years Protecting What’s Right for individuals, communities, and governmental entities, Baron and Budd is a well-established law firm devoted to making a positive difference. With offices in Dallas, Austin, Los Angeles and Baton Rouge, Baron and Budd is able to take on complicated and expensive cases within the realms of dangerous drugs and medical devices, asbestos-related illnesses, consumer fraud, water contamination, the Gulf oil spill and fraudulent financial practices.


Contact